![Maternal characteristics and causes associated with refractory postpartum haemorrhage after vaginal birth: a secondary analysis of the WHO CHAMPION trial data - Widmer - 2020 - BJOG: An International Journal of Obstetrics Maternal characteristics and causes associated with refractory postpartum haemorrhage after vaginal birth: a secondary analysis of the WHO CHAMPION trial data - Widmer - 2020 - BJOG: An International Journal of Obstetrics](https://obgyn.onlinelibrary.wiley.com/cms/asset/92c0c20e-ccc0-4969-8427-9a91249cc6f6/bjo16040-fig-0002-m.jpg)
Maternal characteristics and causes associated with refractory postpartum haemorrhage after vaginal birth: a secondary analysis of the WHO CHAMPION trial data - Widmer - 2020 - BJOG: An International Journal of Obstetrics
![Formative research to design an implementation strategy for a postpartum hemorrhage initial response treatment bundle (E-MOTIVE): study protocol | Reproductive Health | Full Text Formative research to design an implementation strategy for a postpartum hemorrhage initial response treatment bundle (E-MOTIVE): study protocol | Reproductive Health | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12978-021-01162-3/MediaObjects/12978_2021_1162_Fig1_HTML.png)
Formative research to design an implementation strategy for a postpartum hemorrhage initial response treatment bundle (E-MOTIVE): study protocol | Reproductive Health | Full Text
![RBC Red Blood Cells FFP Fresh frozen plasma HES Hydroxyethyl starch RCT Randomised controlled trial FIB-PPH Trial acronym: “FIBrinogen as initial treatment for PostPartum Haemorrhage” GRADE Grading of Recommendations Assessment, Develop- RBC Red Blood Cells FFP Fresh frozen plasma HES Hydroxyethyl starch RCT Randomised controlled trial FIB-PPH Trial acronym: “FIBrinogen as initial treatment for PostPartum Haemorrhage” GRADE Grading of Recommendations Assessment, Develop-](https://d3i71xaburhd42.cloudfront.net/ba2e09307cf31dd935885b5158e3d627feb16469/2-Table1-1.png)